Condition
Hyperinflammatory Syndrome
Total Trials
3
Recruiting
1
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
1Total
P 2 (1)
Trial Status
Recruiting1
Not Yet Recruiting1
Active Not Recruiting1
Clinical Trials (3)
Showing 3 of 3 trials
NCT05611710Phase 2Active Not Recruiting
Anakinra in Dengue With Hyperinflammation ( AnaDen )
NCT06820905Not Yet Recruiting
Hyperinflammation and Hyperferritinemia in Critically Ill Patients
NCT06222866Recruiting
Anticoagulation and Inflammation Monitoring in Patients After Heart and Vascular Interventions
Showing all 3 trials